The Pennant Group, Inc. (NASDAQ:PNTG) Shares Bought by Barclays PLC

Barclays PLC grew its holdings in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 375.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,101 shares of the company’s stock after purchasing an additional 38,763 shares during the period. Barclays PLC owned about 0.14% of The Pennant Group worth $1,753,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its position in The Pennant Group by 10.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 130,195 shares of the company’s stock valued at $3,019,000 after buying an additional 12,141 shares during the period. Principal Financial Group Inc. boosted its holdings in The Pennant Group by 9.9% in the second quarter. Principal Financial Group Inc. now owns 11,029 shares of the company’s stock valued at $256,000 after purchasing an additional 991 shares during the period. Rhumbline Advisers boosted its holdings in The Pennant Group by 8.9% in the second quarter. Rhumbline Advisers now owns 44,239 shares of the company’s stock valued at $1,026,000 after purchasing an additional 3,611 shares during the period. Federated Hermes Inc. grew its stake in The Pennant Group by 600.0% during the 2nd quarter. Federated Hermes Inc. now owns 54,045 shares of the company’s stock worth $1,253,000 after purchasing an additional 46,324 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in The Pennant Group by 17.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 17,486 shares of the company’s stock worth $406,000 after purchasing an additional 2,549 shares during the period. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Price Performance

Shares of NASDAQ:PNTG opened at $25.82 on Friday. The Pennant Group, Inc. has a 12 month low of $14.84 and a 12 month high of $37.13. The firm has a market capitalization of $886.87 million, a P/E ratio of 37.97, a P/E/G ratio of 2.99 and a beta of 1.93. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The company’s fifty day moving average price is $29.59 and its 200 day moving average price is $30.63.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on PNTG. Wells Fargo & Company began coverage on shares of The Pennant Group in a research note on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 price target for the company. Truist Financial decreased their price objective on shares of The Pennant Group from $38.00 to $32.00 and set a “hold” rating for the company in a research report on Monday, January 6th. Oppenheimer increased their target price on The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a report on Friday, November 8th. Royal Bank of Canada lifted their price target on The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a report on Wednesday, October 23rd. Finally, Stephens reiterated an “overweight” rating and issued a $40.00 price objective on shares of The Pennant Group in a report on Wednesday, October 9th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $36.00.

The Pennant Group Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.